Drug Shortage Report for KETALAR

Last updated on 2021-01-12 History
Report ID 131448
Drug Identification Number 00224405
Brand name KETALAR
Common or Proper name KETALAR
Company Name ERFA CANADA 2012 INC
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10ML VIAL
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-01-01
Actual start date 2021-01-04
Estimated end date 2021-01-29
Actual end date
Shortage status Actual shortage
Updated date 2021-01-12
Company comments
Health Canada comments
Contact Address 8250 BLVD DECARIE, SUITE 110
MONTREAL, QUEBEC
CANADA H4P 2P5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-01-12 French Compare
v2 2021-01-12 English Compare
v1 2021-01-12 English Compare